crc

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer
Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative …
PDF Cite Project DOI
An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer
Additional markers of response to anti-EGFR therapy in metastatic colon cancer: Morphological context matters
PDF Project Poster DOI
Identification of high risk patients in stage II pT3N0 microsatellite-stable colorectal cancer
PDF Project Poster DOI
QBI SABI 2023

The Spatial Analysis for Biological Imaging workshop.

Mar 27, 2023 1 min read
QBI SABI 2023
Importance of tumor sampling in transcriptomics-based risk stratification
PDF Cite Project Poster
The impact of tumour morphology landscape on molecular signatures
PDF Project Poster
Molecular portraits of major morphological components of colon tumors
We investigate the molecular landscape of the morphotypes.
Molecular portraits of major morphological components of colon tumors
Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression
Long-term dysbiosis of the gut microbiome has a significant impact on colorectal cancer (CRC) progression and explains part of the …
PDF Cite Project Project DOI
Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression
Consensus molecular subtypes of morphological regions on colorectal tumors
Background The consensus molecular subtypes (CMS) of colon cancer integrated the results of several different subtyping efforts and led …
PDF Cite Project Poster
An explorative analysis of ABCG2/TOP-1 mRNA expression as a biomarker test for FOLFIRI treatment in stage III colon cancer patients: results from retrospective analyses of the PETACC-3 trial
Biomarker-guided treatment for patients with colon cancer is needed. We tested ABCG2 and topoisomerase 1 (TOP1) mRNA expression as …
PDF Cite Project DOI
An explorative analysis of ABCG2/TOP-1 mRNA expression as a biomarker test for FOLFIRI treatment in stage III colon cancer patients: results from retrospective analyses of the PETACC-3 trial